• Latest Posts

Discovery could lead to cancer drugs with fewer side effects

Sponsored by 3 Apr 2023

BIO-Europe Spring 2023: The Highlights

Sofinnova Partners dives into digital medicine, funds new companies

Ablaze Pharmaceuticals to develop first-in-class therapy for liver cancer in China

Destiny Pharma gel reduces nasal staph in surgery patients  

Candidate found to inhibit malignant melanoma growth

ADVERTISEMENT

€260M fund addresses dementia investment shortfall

Podcast 31 Mar 2023

Beyond Biotech podcast 40: Antibody-drug conjugates

Vaccitech announces positive topline data for chronic hepatitis study

ADVERTISEMENT